细胞收集系统市场份额，规模，趋势，行业分析通过技术报告（核转移改变，斑点提取）;通过施用（脐带，骨髓，外周血，脂肪组织，其他来源）;通过最终用户（生物技术和生物制药公司，研究机构，医院，诊所，其他）;按地区，分部预测，2020 - 2026年

Report Summary

The global cell harvesting systems market was valued at USD 4,685.8 million in 2019 and is expected to exhibit a CAGR of 13.9% from 2020 to 2026. Increasing investments in regenerative medicine and cell-based research, growing生物技术和生物制药部门，增加了慢性和传染病的发病率是细胞收获市场增长的主要因素。移植的增加率和对干细胞银行的不断增加的需求也是一些可用于增加全球收获要求的变量。脂肪组织，脐带和胚胎干细胞等新的干细胞来源具有巨大的癌症治疗和再生产品的潜力，使与这些来源有关的研究。

根据世界卫生组织（世卫组织），预计慢性疾病预计到2020年增加了57％。由于慢性疾病，对医疗保健系统的需求增加成为乐动娱乐官网了一个重大问题。疾病控制和预防中心（CDC）表示，慢性疾病是2019年美国死亡和残疾的主要原因，13300万美国人之间至少存在慢性病。45％的人口。此外，与年龄相关和生活方式相关的慢性疾病的上升增加了医疗保健需求和支出。乐动娱乐官网由于城市化，久坐的生活方式，转移饮食，肥胖率的增加，烟草产品的广泛可达性，癌症和心脏病正在成为新兴经济体中死亡的主要原因。市场增长的重大因素是潜在使用干细胞治疗多种慢性疾病。预计增加慢性和传染病发生率，以刺激行业的发展。

Know more about this report:请求样本页面

Cell harvesting systems market is experiencing rapid development due to increased processes for bone marrow transplantation due to elevated blood cancer and anemia prevalence. In addition, enhancing spending on healthcare, survival after therapy, increasing investment in logistics facilities, expanding cardiac bone marrow transplant registry along with neuronal illnesses, and increasing healthcare expenditure per capita.

Cell harvesting is a method of gathering stem cells with healthy functioning ones to regenerate, transplant or repair the damaged organ. In the biopharmaceutical manufacturing industry, cell harvesting is regarded a significant step that can directly influence the quality of the product and associated downstream procedures. The harvesting of stem cells enables to treat illnesses such as cancers, blood disorders, illnesses of immune deficiency and multiple accidents. This treatment is also useful for victims of burning, which helps them to grease fresh skin cells as a substitute for those damaged. Many businesses focus on myocardial tissue regeneration through cell graft injection consisting of patients ' adult stem cells for the production of regenerating drugs.

Cell harvesting mechanism enables with fewer punctures to reduce the invasiveness of bone marrow aspiration from the iliac bone. It also helps to reduce process time and T-cell contamination. However, a significant barrier to the cell harvesting industry is high cost of cumbersome therapy, immunological rejection, absence of reimbursement measures, and identification of stem cells in adult tissues, feasible cell density, and complications during cell harvesting and insufficient amount of transplant HSC cells.

细胞收集系统市场报告范围

该市场主要基于类型，应用，最终用户和地理区域进行分段。

通过技术	By Application	By End Users	By Region Type
Altered Nuclear Transfer Blastomere提取	脐带 Bone marrow Peripheral blood 脂肪组织 Other sources	生物技术与生物制药公司 Research Institutes Hospitals 诊所 其他	North America (U.S., Canada) Europe (Germany, UK, France, Italy, Spain) 亚太（中国，韩国，日本，印度） Latin America (Brazil, Mexico, Colombia) MEA（沙特阿拉伯，南非，以色列，阿联酋）

Know more about this report:请求样本页面

Application Overview

Stem cell research is anticipated to be the fastest growing application segment during the forecast period. Research on human stem cells has huge potential to contribute to understanding basic human biology. Studying stem cells helps researchers better comprehend how the body functions and how the disease grows and impacts the body. Research on stem cell helps scientists comprehend distinct illnesses and circumstances better and find fresh treatments. Human stem cell research should be incorporated into the mainstream of biomedical research, including cell degenerative process study, disease modeling, toxicological and pharmaceutical screening platform development, and regenerative therapy. According to information released by the National Health Institute, around 60,000 patients are treated globally annually with bone marrow transplantation (BMT). The stem cells derived from the bone marrow may advance the study of stem cell biology, stem cell therapy, and regenerative medicine. Therefore, the market is anticipated to experience elevated development over the forecast period due to the above-mentioned factors.

Regional Outlook

据估计，北美在细胞收集系统行业中持有大量份额，预计预测期间的相似趋势，而不会发生重大变化。由于研究支出和公共项目增加，美国产业占据了细胞收获行业。目前由FDA批准的唯一基于干细胞的产品用于U.S.血液形成干细胞。这些以及来自骨髓的干细胞，经常用于治疗移植过程中癌症和血液和免疫系统疾病的患者。此外，美国的医疗保健支出正乐动娱乐官网在上升。These factors are the key components that increase the market's development and make it stable in the U.S. However, in the U.S., a 2019 study discovered hundreds of hospitals in the U.S. selling unapproved stem cell medicines that are likely to hamper market development in the U.S., which is likely to hamper market development.

竞争格局

在细胞收集系统市场中运营的关键参与者包括Perkinelmer Inc. Tomtec，Bertin Technologies，Terumo Bct，Inc。，赫尼托AG，Avita Medical，Argos Technologies，Inc.，SP科学器，Teleflex Incorporated。，Arthrex，Inc。，托马斯科学，品牌GmbH。公共当局的基于干细胞的研究的投资增长和衰老人口的增加可以归因于这些国家对这些疗法的日益增长的需求。这反过来正在为电池收获市场提供主要的球员，以利用全球市场提供的机会。